Followers | 839 |
Posts | 120661 |
Boards Moderated | 13 |
Alias Born | 09/05/2002 |
Thursday, June 03, 2021 12:14:49 PM
https://www.businesswire.com/news/home/20210602006079/en
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent OGN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2024 12:06:35 PM
- 米国FDAが、PROLIA/XGEVA(デノスマブ)のバイオシミラー候補HLX14の生物学的製剤承認申請(BLA)を受理 • Business Wire • 10/31/2024 12:40:00 PM
- 美國FDA接受PROLIA/XGEVA(地諾單抗)生物學名藥候選藥物HLX14的生物製品授權申請(BLA) • Business Wire • 10/31/2024 12:39:00 PM
- US-amerikanische FDA akzeptiert BLA für HLX14 – den Biosimilar-Kandidat zu PROLIA/XGEVA (Denosumab) • Business Wire • 10/31/2024 12:39:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 12:00:35 PM
- Organon Reports Results for the Third Quarter Ended September 30, 2024 • Business Wire • 10/31/2024 11:30:00 AM
- La FDA des États-Unis accepte la demande de licence de produits biologiques (BLA) pour HLX14, le candidat biosimilaire de PROLIA/XGEVA (denosumab) • Business Wire • 10/31/2024 04:02:00 AM
- US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab) • Business Wire • 10/30/2024 10:00:00 AM
- Organon conclut l'acquisition de Dermavant, qui propose notamment un traitement dermatologique innovant : la crème VTAMA® (tapinarof) 1 % • Business Wire • 10/29/2024 04:22:00 PM
- Organon vollzieht Übernahme von Dermavant einschließlich der innovativen dermatologischen Therapie VTAMA® (Tapinarof) Creme, 1 % • Business Wire • 10/29/2024 04:22:00 PM
- オルガノン、ダーマバントの買収を完了し、画期的な皮膚科治療薬VTAMA®(タピナロフ)クリーム1%を取得 • Business Wire • 10/29/2024 04:22:00 PM
- Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% • GlobeNewswire Inc. • 10/28/2024 01:25:00 PM
- Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% • Business Wire • 10/28/2024 01:25:00 PM
- Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024 • Business Wire • 10/09/2024 11:30:00 AM
- Organon Canada Promotes Geneviève Gauthier as Executive Director, Corporate Affairs and Community Engagement and Appoints Jeffrey Malawski as Executive Director, Women's Health and Established Brands • PR Newswire (Canada) • 10/08/2024 12:01:00 PM
- Organon Canada promeut Geneviève Gauthier au poste de directrice exécutive, Affaires corporatives et Engagement communautaire, et nomme Jeffrey Malawski comme directeur exécutif, Santé des femmes et marques établies • PR Newswire (Canada) • 10/08/2024 12:01:00 PM
- パージェタ(Perjeta®)(ペルツズマブ)バイオシミラー候補HLX11の第3相比較臨床試験で主要評価項目を達成 • Business Wire • 09/30/2024 07:26:00 PM
- Primärer Endpunkt in Phase-3-Vergleichsstudie zu Perjeta® (Pertuzumab) Biosimilar-Kandidat HLX11 erreicht • Business Wire • 09/30/2024 04:17:00 PM
- Critères principal atteint dans une étude clinique comparative de phase 3 sur le candidat biosimilaire HLX11 du Perjeta® (pertuzumab) • Business Wire • 09/30/2024 03:59:00 PM
- Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11 • Business Wire • 09/30/2024 10:00:00 AM
- Organon Canada and the Alberta Women's Health Foundation unite to raise awareness and advocate for universal access to contraception in Canada • PR Newswire (Canada) • 09/26/2024 01:50:00 PM
- Organon Canada et l'Alberta Women's Health Foundation s'unissent pour accroître la sensibilisation et prôner l'accès universel à la contraception au Canada • PR Newswire (Canada) • 09/26/2024 01:49:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:21:47 PM
- オルガノンがDermavantを買収し、画期的な皮膚科治療薬VTAMA®(タピナロフ)クリーム1%を取得 • Business Wire • 09/19/2024 06:30:00 PM
- Organon acquiert Dermavant et sa thérapie dermatologique innovante, la crème VTAMA® (tapinarof), 1 % • Business Wire • 09/19/2024 12:00:00 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM